Alembic Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 0.14%

Alembic Pharmaceuticals Limited (APLLTD) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read APLLTD total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Rs121.50 Million
≈ $1.31 Million USD Cash + Short-term Investments

Total Assets

Rs83.97 Billion
≈ $908.10 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Alembic Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See APLLTD total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Alembic Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see APLLTD market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs121.50 Million 0.14%
Total Liquid Assets Rs121.50 Million 0.14%

Asset Resilience Insights

  • Limited Liquidity: Alembic Pharmaceuticals Limited maintains only 0.14% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Alembic Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Alembic Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Alembic Pharmaceuticals Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Alembic Pharmaceuticals Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.23% Rs181.50 Million
≈ $1.96 Million
Rs77.73 Billion
≈ $840.61 Million
-0.19pp
2024-03-31 0.42% Rs271.30 Million
≈ $2.93 Million
Rs64.46 Billion
≈ $697.07 Million
+0.15pp
2023-03-31 0.27% Rs166.40 Million
≈ $1.80 Million
Rs61.83 Billion
≈ $668.65 Million
-0.17pp
2022-03-31 0.44% Rs316.20 Million
≈ $3.42 Million
Rs71.22 Billion
≈ $770.22 Million
-2.34pp
2021-03-31 2.79% Rs1.87 Billion
≈ $20.22 Million
Rs67.09 Billion
≈ $725.55 Million
-0.34pp
2020-03-31 3.12% Rs1.87 Billion
≈ $20.22 Million
Rs59.89 Billion
≈ $647.69 Million
+2.93pp
2019-03-31 0.19% Rs91.00 Million
≈ $984.13K
Rs47.78 Billion
≈ $516.70 Million
-0.12pp
2018-03-31 0.31% Rs121.80 Million
≈ $1.32 Million
Rs39.41 Billion
≈ $426.21 Million
-1.56pp
2017-03-31 1.87% Rs503.40 Million
≈ $5.44 Million
Rs26.87 Billion
≈ $290.55 Million
+5.31pp
2016-03-31 -3.44% Rs-846.16 Million
≈ $-9.15 Million
Rs24.59 Billion
≈ $265.97 Million
--
pp = percentage points

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic
Market Cap
$1.60 Billion
Rs148.41 Billion INR
Market Cap Rank
#7108 Global
#323 in India
Share Price
Rs755.00
Change (1 day)
-0.80%
52-Week Range
Rs646.55 - Rs1039.10
All Time High
Rs1247.70
About

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal healt… Read more